A Comparative View on Human Somatic Cell Sources for iPSC Generation
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
The breakthrough of reprogramming human somatic cells was achieved in 2006 by the work of Yamanaka and Takahashi. From this point, fibroblasts are the most commonly used primary somatic cell type for the generation of induced pluripotent stem cells (iPSCs). Various characteristics of fibroblasts supported their utilization for the groundbreaking experiments of iPSC generation. One major advantage is the high availability of fibroblasts which can be easily isolated from skin biopsies. Furthermore, their cultivation, propagation, and cryoconservation properties are uncomplicated with respect to nutritional requirements and viability in culture. However, the required skin biopsy remains an invasive approach, representing a major drawback for using fibroblasts as the starting material. More and more studies appeared over the last years, describing the reprogramming of other human somatic cell types. Cells isolated from blood samples or urine, as well as more unexpected cell types, like pancreatic islet beta cells, synovial cells, or mesenchymal stromal cells from wisdom teeth, show promising characteristics for a reprogramming strategy. Here, we want to highlight the advantages of keratinocytes from human plucked hair as a widely usable, noninvasive harvesting method for primary material in comparison with other commonly used cell types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reprogramming efficiency is also higher for these two cell types and requires relatively less time for reprogramming [11,12].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299 · cited 1×
“On the other hand, its oncogenic potential suggests its omission for clinical applications [19].”
BackgroundHematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
Epigenetic memory in induced pluripotent stem cells
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., et al. (2010) · Nature · doi:10.1038/nature09342 · Cited by 2,313 · cited 1×
“the epigenetic memory after prolonged iPS cell culture which leads to the conclusion that the primary cell source may not be absolutely essential for redifferentiation [34, 35].”
BackgroundGeneration of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009 · cited 2×
“Moreover, also these systems exhibit a low reprogramming efficiency compared to other systems [10, 21].”
BackgroundMethodGeneration of Induced Pluripotent Stem Cells Using Recombinant Proteins
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788
Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606 · cited 1×
“To avoid the use of integrating viruses, other reprogramming approaches, for example, the use of Sendai viruses [9], plasmids [10], modified RNA [11], or small molecules [12, 13], have been described.”
MethodHotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G., Antosiewicz-Bourget, J., O’Malley, R., Castanon, R., Klugman, S., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,549 · cited 1×
“The general reprogramming process changes the transcriptome and chromatin state of the somatic cell to that of a pluripotent cell [24].”
Background
Research works printed but not linked: 3
- 2013, Acta Naturae, 5, 15
- 10.1126/science.2420009 · doi:10.1126/science.2420009 · Paper page
- 2001, Journal of the National Cancer Institute. Monographs, 7
Cited by
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Akhtar, A., Andleeb, A., Waris, T. S., Bazzar, M., Moradi, A.-R., Awan, N. R., & Yar, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.021 · Cited by 240
Origin and functional heterogeneity of fibroblasts
LeBleu, V. S., & Neilson, E. G. (2020) · The FASEB Journal · doi:10.1096/fj.201903188r · Cited by 219
Kim, S., Lee, S., Kim, H., & Kim, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103119 · Cited by 215
“For example, urinary cells would be an optimal for iPSC generation due to the relative easiness of cell acquisition [22].”
BackgroundHohwieler, M., Illing, A., Hermann, P. C., Mayer, T., Stockmann, M., Perkhofer, L., Eiseler, T., Antony, J. S., Müller, M., Renz, S., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312423 · Cited by 210
Self-citationCAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
Gunaydin, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668349 · Cited by 202
Schmidt, B. Z., Lehmann, M., Gutbier, S., Nembo, E., Noel, S., Smirnova, L., Forsby, A., Hescheler, J., Avci, H. X., Hartung, T., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1805-9 · Cited by 182
Good Cell Culture Practice for stem cells and stem-cell-derived models
Pamies, D. (2016) · ALTEX · doi:10.14573/altex.1607121 · Cited by 160
Smith, A. S. T., Macadangdang, J. R., Leung, W. W., Laflamme, M. A., & Kim, D. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.002 · Cited by 169
“Anin-depthdiscussion of the different methods for deriving iPSCs is beyond the scope of this review, but has been discussed in detail elsewhere (Malik and Rao, 2013; Raab et al., 2014; Sommer and Mostoslavsky, 2013).”
Poetsch, M. S., Strano, A., & Guan, K. (2022) · Stem Cells · doi:10.1093/stmcls/sxac020 · Cited by 144
Autologous Induced Pluripotent Stem Cell–Based Cell Therapies: Promise, Progress, and Challenges
Madrid, M., Sumen, C., Aivio, S., & Saklayen, N. (2021) · Current Protocols · doi:10.1002/cpz1.88 · Cited by 126
Logan, S., Arzua, T., Canfield, S. G., Seminary, E. R., Sison, S. L., Ebert, A. D., & Bai, X. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180025 · Cited by 151
Kandasamy, K., Chuah, J. K. C., Su, R., Huang, P., Eng, K. G., Xiong, S., Li, Y., Chia, C. S., Loo, L., & Zink, D. (2015) · Scientific Reports · doi:10.1038/srep12337 · Cited by 112
“Cell samples from patients affected by kidney disease or adverse drug effects could be obtained from skin, blood or urine 51 and differentiated into HPTC-like cells after reprogramming into hiPSC.”
BackgroundThe potential of induced pluripotent stem cell derived hepatocytes
Hannoun, Z., Steichen, C., Dianat, N., Weber, A., & Dubart‐Kupperschmitt, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.025 · Cited by 113
“6 less ethical concerns and can be generated from unlimited sources with varying genetic backgrounds [11].”
BackgroundNie, Y.-Z., Zheng, Y.-W., Ogawa, M., Miyagi, E., & Taniguchi, H. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0749-1 · Cited by 98
“Human iPSCs have been reprogrammed successfully from different types of donor somatic cells, including fibroblasts, UC blood cells, and ECs [21].”
Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies
Naderi‐Meshkin, H., Cornelius, V. A., Eleftheriadou, M., Potel, K. N., Setyaningsih, W. A. W., & Margariti, A. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03521-2 · Cited by 108
“Human iPSCs have been derived from various cell sources, including fibroblasts [7], keratinocytes, and mononuclear cells from healthy individuals or patients [22, 107, 108].”
BackgroundOsteogenesis Imperfecta: Current and Prospective Therapies
Botor, M., Fus-Kujawa, A., Uroczynska, M., Stępień, K., Galicka, A., Gawron, K., & Sieroń, A. L. (2021) · Biomolecules · doi:10.3390/biom11101493 · Cited by 109
“The hydrophobicity of the plasma membrane and the large size of the introduced proteins may be overcome by fusion of the proteins with a Cell Penetrating Peptide (CPP) such as trans-activator of transcription (TAT) or 11-Arginine residues (11R) [55,59].”
BackgroundInduced pluripotent stem cells for neural drug discovery
Farkhondeh, A., Li, R., Gorshkov, K., Chen, K. G., Might, M., Rodems, S., Lo, D. C., & Zheng, W. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.01.007 · Cited by 91
“Although iPSCs can be used extensively in drug discovery and cell therapy without ethical constraints, there are still limitations such as incomplete cellular reprogramming and the genetic and epigenetic changes that can occur with prolonged culturing of iPSCs [10,11].”
BackgroundIn vitro modeling of blood–brain barrier and interface functions in neuroimmune communication
Erickson, M. A., Wilson, M., & Banks, W. A. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00187-3 · Cited by 104
Myofibroblast progeny in wound biology and wound healing studies
Monika, P., Waiker, P. V., Chandraprabha, M. N., Rangarajan, A., & Murthy, K. N. C. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12937 · Cited by 96
“Thus, it is appears that fibroblasts are highly plastic and exhibit multipotency.(33,34) It is interesting to know that iPSCs were first engineered using activated fibroblasts, and these cells remain the most efficient cellular source for iPSC reprogramming.”
BackgroundGao, X., & Liu, Y. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9383-z · Cited by 87
Scalable microphysiological system to model three-dimensional blood vessels
de Graaf, M. N. S., Cochrane, A., van den Hil, F. E., Buijsman, W., van der Meer, A. D., van den Berg, A., Mummery, C. L., & Orlova, V. V. (2019) · APL Bioengineering · doi:10.1063/1.5090986 · Cited by 71
Bahmad, H. F., Hadadeh, O., Chamaa, F., Cheaito, K. A., Darwish, B., Makkawi, A.-K., & Abou-Kheir, W. G. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00050 · Cited by 76
“This can usually be overcome by using a low passage not exceeding passage 5 in order to avoid accumulated genomic changes (Raab et al., 2014).”
BackgroundAgu, C. A., Soares, F. A. C., Alderton, A., Patel, M., Ansari, R., Patel, S., Forrest, S., Yang, F., Lineham, J., Vallier, L., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.08.012 · Cited by 63
“Less traumatic, non-invasive methods of collecting cells for reprogramming from blood, hair follicle, and urine have been described (Raab et al., 2014).”
Moerkens, R., Mooiweer, J., Ramírez-Sánchez, A. D., Oelen, R., Franke, L., Wijmenga, C., Barrett, R. J., Jonkers, I. H., & Withoff, S. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114247 · Cited by 75
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Giacomelli, E., Mummery, C. L., & Bellin, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2546-5 · Cited by 60
“Many methods have now been described that allow somatic cell reprogramming [13].”
MethodBang, S., Lee, S., Choi, N., & Kim, H. N. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002119 · Cited by 60
Fibroblasts as Turned Agents in Cancer Progression
Wieder, R. (2023) · Cancers · doi:10.3390/cancers15072014 · Cited by 57
Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB
Young-Baird, S. K., Lourenço, M. B., Elder, M. K., Klann, E., Liebau, S., & Dever, T. E. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.11.008 · Cited by 52
“Patient and WT control keratinocytes were isolated from plucked hair that presented with a healthy outer root sheath and reprogrammed to iPSCs as previously described (Raab et al., 2014; Raab et al., 2017).”
MethodSelf-citationNanomaterials for Bone Tissue Regeneration: Updates and Future Perspectives
Hill, M. J., Qi, B., Bayaniahangar, R., Araban, V., Bakhtiary, Z., Doschak, M. R., Goh, B. C. K., Shokouhimehr, M., Vali, H., Presley, J. F., et al. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0445 · Cited by 54
Wruck, W., Graffmann, N., Kawala, M.-A., & Adjaye, J. (2016) · Stem Cells · doi:10.1002/stem.2454 · Cited by 52
Ray, A., Joshi, J. M., Sundaravadivelu, P. K., Raina, K., Lenka, N., Kaveeshwar, V., & Thummer, R. P. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10200-3 · Cited by 59
Models for discovery of targeted therapy in genetic epileptic encephalopathies
Maljevic, S., Reid, C. A., & Petrou, S. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14134 · Cited by 49
“Studies suggest that iPSCs are affected by the epigenetic properties of the source tissue and the age of the donor, but prolonged culturing can reduce this epigenetic imprinting (Raab et al. 2014; Lo et al. 2017).”
BackgroundA Cleared View on Retinal Organoids
Cora, V., Haderspeck, J., Antkowiak, L., Mattheus, U., Neckel, P. H., Mack, A. F., Bolz, S., Ueffing, M., Pashkovskaia, N., Achberger, K., et al. (2019) · Cells · doi:10.3390/cells8050391 · Cited by 50
“hiPSC lines were derived from keratinocytes of healthy donors as previously described [20].”
MethodSelf-citationLi, P., Zhang, H., Chen, T., Zhou, Y., Yang, J., & Zhou, J. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.06.004 · Cited by 53
A non-invasive method to generate induced pluripotent stem cells from primate urine
Geuder, J., Wange, L. E., Janjic, A., Radmer, J., Janssen, P., Bagnoli, J., Müller, S., Kaul, A., Ohnuki, M., & Enard, W. (2021) · Scientific Reports · doi:10.1038/s41598-021-82883-0 · Cited by 51
Steinle, H., Weber, M., Behring, A., Mau-Holzmann, U. A., OHLE, C. V., Popov, A., Schlensak, C., Wendel, H. P., & Avci‐Adali, M. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.07.016 · Cited by 45
“Hitherto, human fibroblasts have been the most commonly used cell source for reprogramming studies.(14) Fibroblasts are usually obtained from skin biopsies, which represent an invasive procedure and lead to an injury of healthy tissue.”
Urine-derived stem/progenitor cells: A focus on their characterization and potential
Burdeyron, P., Giraud, S., Hauet, T., & Steichen, C. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i10.1080 · Cited by 44
Biomaterial-based cell delivery strategies to promote liver regeneration
Ali, M., & Payne, S. L. (2021) · Biomaterials Research · doi:10.1186/s40824-021-00206-w · Cited by 46
iPSC Bioprinting: Where are We at?
Romanazzo, S., Nemec, S. R., & Roohani, I. (2019) · Materials · doi:10.3390/ma12152453 · Cited by 47
de Korte, T., Katili, P. A., Yusof, N. A. N. M., van Meer, B. J., Saleem, U., Burton, F. L., Smith, G. L., Clements, P., Mummery, C. L., Eschenhagen, T., et al. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023309 · Cited by 45
Restoring Motor Neurons in Spinal Cord Injury With Induced Pluripotent Stem Cells
Trawczynski, M., Liu, G., David, B. T., & Fessler, R. G. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00369 · Cited by 43
Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation
van Gorp, P. R. R., Trines, S. A. I. P., Pijnappels, D. A., & de Vries, A. A. F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00043 · Cited by 42
Scuto, M. C., Modafferi, S., Rampulla, F., Zimbone, V., Tomasello, M., Spanò, S. M., Ontario, M. L., Palmeri, A., Salinaro, A. T., Siracusa, R., et al. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111686 · Cited by 43
Navarro, A. M., Susanto, E., Falk, A., & Wilhelm, M. (2018) · Cell Death Discovery · doi:10.1038/s41420-017-0009-2 · Cited by 42
Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
Tousley, A. R., & Kegel-Gleason, K. B. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160199 · Cited by 39
“iPSCs have been successfully created from a variety of somatic cell types including fibroblasts [1, 3], blood cells [5, 6], renal epithelial cells [7], and keratinocytes [8, 9].”
BackgroundPatient-derived induced pluripotent stem cells for modelling genetic retinal dystrophies
Foltz, L. P., & Clegg, D. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.09.002 · Cited by 39
D’Aloia, A., Pastori, V., Blasa, S., Campioni, G., Peri, F., Sacco, E., Ceriani, M., Lecchi, M., & Costa, B. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01790-7 · Cited by 36
“…and the genetic and epigenetic changes that can occur with prolonged culturing of iPSCs further limit the usage of this in vitro model [13 – 15]. iPSC-derived neurons (iPSCNs) show heterogeneous electrophysiological properties (action potential fi ring frequency, action potential amplitude,…”
Application of Biomaterials in Diabetic Wound Healing: The Recent Advances and Pathological Aspects
Han, C., Singla, R. K., & Wang, C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101295 · Cited by 41
“…from various stem cells [217] and somatic cells [218], with fibroblasts being the earliest and most commonly used cells for iPSC generation [219]. iPSCs can differentiate into all cell types in the skin with low autoimmune responses, thus being considered a promising therapeutic option for…”
Advances in stem cell research for the treatment of primary hypogonadism
Li, L., & Papadopoulos, V. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00480-2 · Cited by 40
Misra, S., Hascall, V. C., Markwald, R. R., O’Brien, P. E., & Ghatak, S. (2017) · Wiley eBooks · doi:10.1002/9781119282518.ch18 · Cited by 35
Blood–Labyrinth Barrier in Health and Diseases: Effect of Hormetic Nutrients
Cosentino, A., Agafonova, A., Modafferi, S., Salinaro, A. T., Scuto, M. C., Maiolino, L., Fritsch, T., Calabrese, E. J., Lupo, G., Anfuso, C. D., et al. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0251 · Cited by 38
“…concerns associated with ESCs and, being generated from adult tissues such as skin, blood or urine represents a limitless source of human-relevant models, enabling experimental studies that are difficult or impossible to conduct in human subjects (Raab et al., 2014; Torrens-Mas et al., 2021).”
Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications
Xu, Q. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.730008 · Cited by 39
“To generate hiPSCs, reprogramming factors can be integrated into somatic cell genomes via single-cassette vectors (Cre-Lox), mRNA or miRNA transfection, episomal plasmids, or non-integrating viral vectors (Takahashi et al., 2007; Raab et al., 2014; Ramboer et al., 2015; Mitani et al., 2017; Ang et al., 2018; Dao Thi e…”
Hessel, E. V. S., Staal, Y. C. M., & Piersma, A. H. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.03.013 · Cited by 42
Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
Nath, S. C., Menendez, L., & Friedrich Ben-Nun, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316929 · Cited by 35
Balan, S., Toyoshima, M., & Yoshikawa, T. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.021 · Cited by 33
Genetic circuits to engineer tissues with alternative functions
Healy, C. P., & Deans, T. L. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0170-7 · Cited by 29
Celiac disease‐on‐chip: Modeling a multifactorial disease in vitro
Moerkens, R., Mooiweer, J., Withoff, S., & Wijmenga, C. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619836057 · Cited by 36
“With the development of improved protocols, hiPSC lines can now be efficiently generated from urine-derived epithelial cells and bloodderived erythroblasts, among others.(48) Using knowledge on embryonic development, hiPSCs can be differentiated into human intestinal organoids (HIOs): miniature parts of the gut that a…”
BackgroundPessôa, L. V. D. F., Pires, P. R. L., del Collado, M., Pieri, N. C. G., Recchia, K., Souza, A. F., Perecin, F., da Silveira, J. C., de Andrade, A. F. C., Ambrosio, C. E., et al. (2019) · Stem Cells International · doi:10.1155/2019/1393791 · Cited by 29
“Additionally, it has been reported that fibroblasts present inferior reprogramming rates compared with other cell types [13].”
Induced Pluripotent Stem Cells: Progress toward Clinical Translation from Bench to Bedside
Fakoya, A. O. J., Omole, A. E., Satyadev, N., & Haider, K. H. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_40-1 · Cited by 29
Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road Ahead
Hokayem, J. A. E., Cukier, H. N., & Dykxhoorn, D. M. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000275 · Cited by 30
“mesenchymal to epithelial transition) to reach a pluripotent state [19].”
BackgroundRe, S., Doğan, A. A., Ben‐Shachar, D., Berger, G. E., Werling, A. M., Walitza, S., & Grünblatt, E. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00321 · Cited by 32
“However, new, more convenient, integration-free systems are immerging, such as RNA vectors or non-integrating viruses (Raab et al., 2014).”
BackgroundThe Use of Induced Pluripotent Stem Cells as a Model for Developmental Eye Disorders
Eintracht, J., Toms, M., & Moosajee, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00265 · Cited by 29
Incorporating Immune Cells into Organoid Models: Essential for Studying Human Disease
Bogoslowski, A., An, M., & Penninger, J. M. (2023) · Organoids · doi:10.3390/organoids2030011 · Cited by 34
“This is also a much cheaper method than iPSC cells to obtain a particular cell of interest [91].”
MethodChiara, L. D., & Crean, J. K. G. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5010006 · Cited by 27
“Keratinocytes, along with others type of epithelial cells, can be reprogrammed faster and with higher success rates compared to non-epithelial cell types [91,92].”
BackgroundRadwan, I. A., Rady, D., Abbass, M. M. S., Moshy, S. E., AbuBakr, N., Dörfer, C. E., & El‐Sayed, K. M. F. (2020) · Stem Cells International · doi:10.1155/2020/1941629 · Cited by 28
“One of the major drawbacks that could hinder iPSCs’ clinical application is their reported chromosomal instability and the underlying risk of tumor formation, which constitutes a substantial health hazard [12, 147].”
BackgroundChallenges with Cell-based Therapies for Type 1 Diabetes Mellitus
Siwakoti, P., Rennie, C., Huang, Y., Li, J. J., Tuch, B. E., McClements, L., & Xu, X. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10482-1 · Cited by 29
Generation of porcine induced-pluripotent stem cells from Sertoli cells
Setthawong, P., Phakdeedindan, P., Tiptanavattana, N., Rungarunlert, S., Techakumphu, M., & Tharasanit, T. (2018) · Theriogenology · doi:10.1016/j.theriogenology.2018.12.033 · Cited by 25
Cellular models for human cardiomyopathy: What is the best option?
Jiménez-Téllez, N., & Greenway, S. C. (2019) · World Journal of Cardiology · doi:10.4330/wjc.v11.i10.221 · Cited by 29
Latoszek, E., & Czeredys, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.657337 · Cited by 26
Liebau, S., Mahaddalkar, P. U., Kestler, H. A., Illing, A., Seufferlein, T. T. W., & Kleger, A. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0461 · Cited by 24
Self-citationSteichen, C., Si‐Tayeb, K., Wulkan, F., Crestani, T., Rosas, G., Dariolli, R., Pereira, A. C., & Krieger, J. E. (2017) · Current Protocols in Human Genetics · doi:10.1002/cphg.26 · Cited by 24
“Advantages of using urine progenitor cells as a substrate for reprogramming Numerous cell types have been shown to be susceptible to reprogramming (Raab et al., 2014).”
BackgroundRim, Y. A., Nam, Y., Park, N., Jung, H., Jang, Y., Lee, J. J., & Ju, J. H. (2018) · Stem Cells International · doi:10.1155/2018/9432616 · Cited by 25
“The inheritance of the initial epigenomes and characteristics of the primary cell source to the hiPSCs are mentioned as “epigenetic memory” [47].”
BackgroundStem cell‐derived organoids to model gastrointestinal facets of cystic fibrosis
Hohwieler, M., Perkhofer, L., Liebau, S., Seufferlein, T. T. W., Müller, M., Illing, A., & Kleger, A. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616670565 · Cited by 23
Self-citationBio-collections in autism research
Reilly, J., Gallagher, L., Chen, J. L., Leader, G., & Shen, S. (2017) · Molecular Autism · doi:10.1186/s13229-017-0154-8 · Cited by 28
“Low passages of fibroblasts are required for reprogramming as higher passages dramatically reduce reprogramming efficiency and increase genomic instability [155].”
BackgroundHuman‐based new approach methodologies to accelerate advances in nutrition research
Cassotta, M., Cianciosi, D., Elexpuru-Zabaleta, M., Elío, I., Cano, S. S., Giampieri, F., & Battino, M. A. (2024) · Food Frontiers · doi:10.1002/fft2.369 · Cited by 28
“…of the body but can be also generated from quite easily accessible somatic cells, including skin-derived fibroblasts, blood-derived erythroblasts, or urine-derived epithelial cells (Raab et al., 2014), and their derivation does not involve destruction of embryos, thus avoiding ethical problems.”
BackgroundPanferov, E., Dodina, M., Reshetnikov, V. V., Ryapolova, A., Ivanov, R. A., Karabelsky, A. V., & Minskaia, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125617 · Cited by 28
Synthetic biology for improving cell fate decisions and tissue engineering outcomes
Vogel, A. M., Persson, K. M., Seamons, T. R., & Deans, T. L. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20190091 · Cited by 23
Pan, T., Chen, Y., Zhuang, Y., Yang, F., Xu, Y., Tao, J., You, K., Wang, N., Wu, Y., Lin, X.-H., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1463-y · Cited by 21
Geraets, I. M. E., Chanda, D., van Tienen, F. H. J., van den Wijngaard, A., Kamps, R., Neumann, D., Liu, Y., Glatz, J. F. C., Luiken, J. J. F. P., & Nabben, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.025 · Cited by 23
Gao, X., Yourick, J. J., & Sprando, R. L. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.11.004 · Cited by 20
“Several other somatic cell types have thereafter been explored for the reprogramming of iPSCs, including renal epithelial cells from urine, keratinocytes from hair follicle, and mononuclear cells (MNCs) from blood samples (Raab et al., 2014; Singh et al., 2015).”
BackgroundShrestha, R., Wen, Y., Ding, D., & Tsai, R. (2019) · Cells · doi:10.3390/cells8010036 · Cited by 22
Recent advances in the induced pluripotent stem cell‐based skin regeneration
Choudhury, S., Surendran, N., & Das, A. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12925 · Cited by 25
“were first used by Yamanaka for both human and mouse iPSC generation.(6,7,25,58) Apart from fibroblasts, blood cells(59,60) and hair keratinocytes(13,61,62) have been widely used for iPSC generation.”
MethodGuerreiro, S. R., & Maciel, P. (2023) · Cells · doi:10.3390/cells12040538 · Cited by 21
“Following the second option, the next step is the selection of the initial study sample from which the hIPSCs will be obtained, involving the collection of the samples, which may be [104]: urine (>30 mL), which is easy to obtain in a non-invasive manner but prone to failure due to the low percentage of transformable c…”
BackgroundGenotoxic Effects of Culture Media on Human Pluripotent Stem Cells
Bangalore, M. P., Adhikarla, S., Mukherjee, O., & Panicker, M. M. (2017) · Scientific Reports · doi:10.1038/srep42222 · Cited by 21
Harb, H., González-de-la-Vara, M. D. R., Thalheimer, L., Klein, U., Renz, H., Rose, M., Kruse, J., Potaczek, D. P., & Peters, E. M. J. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.09.007 · Cited by 19
Rovina, D., Castiglioni, E., Niro, F., Mallia, S., Pompilio, G., & Gowran, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196997 · Cited by 18
“The efficiency, kinetics, and the cocktail of factors necessary for correct reprogramming is different for each cell type [68], with some adult cell types proving more permissive to reprogramming compared to others [23,69].”
BackgroundPars, S., Achberger, K., Kleger, A., Liebau, S., & Pashkovskaia, N. (2021) · Cells · doi:10.3390/cells10010074 · Cited by 20
“Among cell sources for hiPSCs, keratinocytes proved to be one of the best solutions, due to the high reprogramming efficiency and non-invasive harvesting procedure from human hair roots [3].”
BackgroundSelf-citationDepression patient-derived cortical neurons reveal potential biomarkers for antidepressant response
Avior, Y., Ron, S., Kroitorou, D., Albeldas, C., Lerner, V., Corneo, B., Nitzan, E., Laifenfeld, D., & Solal, T. C. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01319-5 · Cited by 21
Punetha, M., Saini, S., Chaudhary, S., Bala, R., Sharma, M., Kumar, P., Kumar, D., & Yadav, P. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102067 · Cited by 22
Current status of stem cell therapy: opportunities and limitations
Rusu, E. E., Necula, L. G., Neagu, A. I., Alecu, M., Stan, C., Albulescu, R., & Tănase, C. (2016) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1506-95 · Cited by 23
“Besides dermal fibroblasts, commonly used as source for hiPSC generation (Takahashi et al., 2007; Yu et al., 2007; Raab et al., 2014), a wide variety of cells were employed: hepatocytes (Liu et al.”
BackgroundUnderstanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients
Lim, C., Yang, J.-E., Lee, Y., Lee, K., Lee, J., & Kaang, B. (2015) · Molecular Brain · doi:10.1186/s13041-015-0146-6 · Cited by 22
Fus-Kujawa, A., Mendrek, B., Trybus, A., Bajdak-Rusinek, K., Stępień, K., & Sieroń, A. L. (2021) · Biomolecules · doi:10.3390/biom11050699 · Cited by 23
“This procedure makes it possible to gather genetically patient-specific stem cells from many types of easily obtainable somatic cells [8].”
BackgroundLv, Y., Rao, Z., Liu, L., Jia, J., Wu, C., Xu, J., Du, Y., Liu, Y., Liu, B., Shi, J., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13540 · Cited by 16
Mitutsova, V., Yeo, W. W. Y., Davaze, R., Franckhauser, C., Hani, E.-H., Abdullah, S., Mollard, P., Schaeffer, M., Fernandez, A., & Lamb, N. J. C. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0539-9 · Cited by 18
Age-Related Epigenetic Derangement upon Reprogramming and Differentiation of Cells from the Elderly
Ravaioli, F., Bacalini, M. G., Franceschi, C., & Garagnani, P. (2018) · Genes · doi:10.3390/genes9010039 · Cited by 19
“Induced pluripotent stem cells have been generated from a large set of different tissues [5] deriving from subjects of different age [14].”
BackgroundFliefel, R. M., Ehrenfeld, M., & Otto, S. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2697 · Cited by 19
“Thus, better alternatives have been recently used to overcome the disadvantages with the use of fibroblasts (Raab et al., 2014).”
Cho, Y. K., Kim, H.-K., Kwon, S. S., Jeon, S.-H., Cheong, J., Nam, K. T., Kim, S., Kim, S., & Kim, H. O. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03305-8 · Cited by 18
“[40], which proposed that the reprogramming efficiency in CB group was high, whereas that in PB group was relatively low.”
BackgroundRoberts, C. L., Chen, S. S., Murchison, A. C., Ogle, R. A., Francis, M. P., Ogle, R. C., & Sachs, P. C. (2017) · Stem Cells International · doi:10.1155/2017/1513281 · Cited by 19
Considerations for using isolated cell systems to understand cardiac metabolism and biology
McNally, L. A., Altamimi, T., Fulghum, K., & Hill, B. G. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.007 · Cited by 17
Metadata
- Authors
- Raab, S., Klingenstein, M., Liebau, S., & Linta, L.
- Affiliations
- University of Tübingen (DE)
- Corresponding author
- Liebau, Stefan
- Linta, Leonhard
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-12
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- PMC
- PMC4241335
- OpenAlex
- W2034460442
- Cited by
- 263
- References
- 83
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 28 · 2023: 21 · 2022: 20 · 2021: 35 · 2020: 27 · 2019: 26 · 2018: 19 · 2017: 21 · 2016: 22 · 2015: 7
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cells International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (DFG, SL BO1718/4-1, F/34/11, 2011 A200)
- German Foundation for Heart Research (DFG, SL BO1718/4-1, F/34/11, 2011 A200)
- Else Kröner-Fresenius-Stiftung (DFG, SL BO1718/4-1, F/34/11, 2011 A200)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, somatic cell reprogramming, keratinocytes, hair follicle, fibroblasts, urine-derived cells, pancreatic beta cells, synoviocytes, mesenchymal stem cells, skin biopsy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.